Sign inCreate account

Report workspace tools

NCT00979693WITHDRAWNanonymous

Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma.

Sponsor

Source record

Multidisciplinary Association for Psychedelic Studies

Phase

Source record

PHASE2

Modality

AI-normalized

small molecule

Target

AI-normalized

psilocybin, psilocybin

Indication / condition

AI-normalized

Anxiety

Intervention

Source record

psilocybin, psilocybin

Source & freshness

Source record

NCT ID

NCT00979693

Original source

ClinicalTrials.gov

Source last updated

Dec 26, 2023

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT00979693

Title

Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma.

Sponsor

Multidisciplinary Association for Psychedelic Studies

Status

WITHDRAWN

Phase

PHASE2

Condition raw

Anxiety

Condition normalized

Anxiety

Modality raw

psychedelic therapy

Modality normalized

small molecule

Target raw

psilocybin, psilocybin

Target normalized

psilocybin, psilocybin

Interventions

psilocybin, psilocybin

Public preview

Source record

Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma. is a PHASE2 clinical asset sponsored by Multidisciplinary Association for Psychedelic Studies in Anxiety, Stage IV Melanoma. SEO and diligence focus: psilocybin, psilocybin, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma.

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT00979693

Status

WITHDRAWN

Phase

PHASE2

Sponsor

Multidisciplinary Association for Psychedelic Studies

Executive brief

Investment-Ready Snapshot

Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma. is a PHASE2 clinical asset sponsored by Multidisciplinary Association for Psychedelic Studies in Anxiety, Stage IV Melanoma. SEO and diligence focus: psilocybin, psilocybin, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedDec 26, 2023
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT00979693

Indication

Anxiety

Modality

small molecule

Target

psilocybin, psilocybin

Intervention

psilocybin, psilocybin

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.